Belumosudil and ruxolitinib combination for treatment of refractory chronic graft-versus-host disease

被引：0
|
作者：
Iskra Pusic
Catherine Lee
Muthu Veeraputhiran
Chelsea Minor
John F. DiPersio
机构：
[1] Washington University School of Medicine,Fred Hutchinson Cancer Center
[2] Division of Oncology,undefined
[3] Clinical Research Division,undefined
[4] University of Arkansas for Medical Sciences,undefined
[5] Department of Hematology and Medical Oncology,undefined
来源：
Bone Marrow Transplantation | 2024年 / 59卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：282 / 284
页数：2
相关论文
共 50 条
  • [11] Ruxolitinib for Chronic Graft-versus-Host Disease
    Shibusawa, Motoharu
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (17): : 1631 - 1631
  • [12] Ruxolitinib treatment for steroid-refractory graft-versus-host disease
    Park, Han-Seung
    Lee, Je-Hwan
    Lee, Jung-Hee
    Choi, Eun-Ji
    Seol, Miee
    Lee, Young-Shin
    Kang, Young-Ah
    Jeon, Mijin
    Lee, Kyoo-Hyung
    BONE MARROW TRANSPLANTATION, 2019, 54 : 323 - 324
  • [13] Ruxolitinib for treatment of Graft-versus-Host Disease
    Krueger, W. H.
    Neumann, T.
    Weigel, M.
    Plis, A.
    Schneidewind, L.
    Vaizian, R.
    Schmidt, C. A.
    ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 70 - 71
  • [14] Ruxolitinib for the treatment of graft-versus-host disease
    Ali, Haris
    Salhotra, Amandeep
    Modi, Badri
    Nakamura, Ryotaro
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2020, 16 (04) : 347 - 359
  • [15] Efficacy and tolerance of ruxolitinib in refractory sclerodermatous chronic graft-versus-host disease
    Hurabielle, C.
    de Fontbrune, F. Sicre
    Moins-Teisserenc, H.
    Robin, M.
    Jachiet, M.
    Coman, T.
    Dhedin, N.
    Cassius, C.
    Chasset, F.
    de Masson, A.
    Michonneau, D.
    Bagot, M.
    Bergeron, A.
    Socie, G.
    de Latour, R. Peffault
    Bouaziz, J-D
    BRITISH JOURNAL OF DERMATOLOGY, 2017, 177 (05) : E206 - E208
  • [16] Combination treatment of extracorporeal photopheresis and belumosudil for chronic graft-versus-host disease (vol 317, 298, 2025)
    Swallow, Madisen A.
    Chang, Jungsoo
    Carlson, Kacie R.
    Odell, Ian
    Girardi, Michael
    ARCHIVES OF DERMATOLOGICAL RESEARCH, 2025, 317 (01)
  • [17] Ruxolitinib as a promising treatment for corticosteroid-refractory graft-versus-host disease
    Assouan, Deborah
    Lebon, Delphine
    Charbonnier, Amandine
    Royer, Bruno
    Marolleau, Jean-Pierre
    Gruson, Berengere
    BRITISH JOURNAL OF HAEMATOLOGY, 2018, 181 (05) : 687 - 689
  • [18] Ruxolitinib: a potential treatment for corticosteroid refractory acute graft-versus-host disease
    Abedin, Sameem M.
    Hamadani, Mehdi
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2020, 29 (05) : 423 - 427
  • [19] Ruxolitinib for Chronic Graft-versus-Host Disease REPLY
    Zeiser, Robert
    Teshima, Takanori
    Locatelli, Franco
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (17): : 1632 - 1632
  • [20] BELUMOSUDIL AND RUXOLITINIB COMBINATION THERAPY FOR TREATMENT OF STEROID-REFRACTORY CHRONIC GRAFTVERSUS-HOST DISEASE
    Pusic, Iskra
    Minor, Chelsea
    Lee, Catherine
    Veeraputhiran, Muthu
    DiPersio, John F.
    BONE MARROW TRANSPLANTATION, 2023, 58 (SUPP1) : 321 - 322
12345